Related Experiment Video

Updated: Jun 10, 2026

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
10:01

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening

Published on: March 31, 2022

Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells

Euclides Avila1, Rocío García-Becerra, Jesús Adrián Rodríguez-Rasgado

  • 1Department of Reproductive Biology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan 14000 Mexico, D.F., Mexico.

Anticancer Research
|August 5, 2010
PubMed
Abstract

Insights

Calcitriol reduces Human ether à-go-go-1 (EAG1) channel expression in normal and cancer cells. This finding suggests calcitriol as a potential therapy for cervical cancer by targeting EAG1.

Area of Science:

  • Molecular biology
  • Oncology
  • Channelopathies

Background:

  • Human ether à-go-go-1 (EAG1) potassium channels are recognized as potential targets for cancer therapy.
  • Calcitriol, a vitamin D metabolite, exhibits known antitumor properties.

Purpose of the Study:

  • To investigate the regulatory effects of calcitriol on EAG1 expression.
  • To explore calcitriol's potential as an anticancer agent by examining its impact on EAG1 in various cell types.

Main Methods:

  • Utilized cancer cell lines (cervix, prostate, mammary gland) and normal placental trophoblasts.
  • Quantified calcitriol levels using High-Performance Liquid Chromatography (HPLC).
  • Assessed gene and protein expression of EAG1 via real-time RT-PCR and Western blotting, respectively. Investigated the roles of CYP27B1 and the vitamin D receptor (VDR) through transfection studies and proliferation assays.

Main Results:

  • Calcitriol significantly decreased EAG1 mRNA levels across all tested cell types.
  • Calcitriol reduced EAG1 protein expression and cell proliferation in cervical cancer (SiHa) cells.
  • The effects of calcitriol on EAG1 mRNA were mediated through the vitamin D receptor (VDR), as evidenced by blockage with a VDR antagonist and enhanced inhibition in VDR-transfected cells.

Conclusions:

  • EAG1 is identified as a direct target of calcitriol in both normal and cancerous cells.
  • Calcitriol demonstrates potential as a therapeutic agent for cervical cancer, likely through its modulation of EAG1 expression.

More Related Videos

Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms13:40

Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms

Published on: July 7, 2011

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates07:42

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates

Published on: October 18, 2018

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...